Latest Revenue Growth News

SportsHero Limited’s new HeroPlay mobile gaming platform is off to a strong start in Indonesia, attracting nearly 300 daily subscribers and generating early revenue that validates its market strategy.

Harmoney Corp Limited reported a staggering 742% increase in Cash NPAT for FY25, driven by its new Stellare® 2.0 platform and operational efficiencies. The company reaffirmed its ambitious $12 million profit target for FY26 while unveiling a secured car loan product and securing a major bank debt facility.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Adherium Limited reports a remarkable 103% quarter-on-quarter growth in Remote Patient Monitoring subscription revenues for Q2 FY26, driven by strong device shipment momentum and strategic operational changes.

Meridian Energy's November 2025 report reveals record-high hydro inflows and storage, alongside increased electricity demand and retail sales across all segments, signaling robust operational momentum.

CTI Logistics Limited anticipates a significant 55% increase in profit before tax for the half year ending December 2025, driven by robust revenue growth and operational improvements in Western Australia.

De.mem Limited has closed a $500,000 unsecured shareholder loan facility to fund the rapid expansion of its recently acquired Core Chemicals business amid strong demand from the gold mining sector.

Neuren Pharmaceuticals’ partner Acadia secures FDA approval for DAYBUE STIX, a new powder formulation of trofinetide offering greater flexibility for Rett syndrome patients. This milestone expands treatment options and sets the stage for increased royalty revenue in 2026.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Aumake Limited has raised $1.5 million through a share placement to strengthen inventory and expand its footprint in China, signaling renewed growth ambitions under a refreshed board.

Axiom Properties, soon to be Axtec Limited, has forged a strategic partnership with Ray White Avi Khan Group to deploy cutting-edge embedded payments and automation solutions across 3,000 properties, aiming to transform real estate transactions and boost recurring revenue.